ARID1A and uterine cancer: Furthermore ARID1A, p53 and ß-Catenin turned out to be three promising prognostic factors showing significant differences in independent survival analysis, indicating that ARID1A, p53 and ß-Catenin could be used along traditional clinical and morphologic factors to predict the prognosis of patients with clear cell and endometrioid ovarian and uterine cancer.